<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01840397</url>
  </required_header>
  <id_info>
    <org_study_id>Wolf-6</org_study_id>
    <nct_id>NCT01840397</nct_id>
  </id_info>
  <brief_title>Neuromarker S-100B as Diagnostic Tool</brief_title>
  <acronym>SpineSurgery</acronym>
  <official_title>Elevated Levels of S-100B and Neuron-specific Enolase (NSE) in Spine Surgery: A Comparison of Serum Levels With Surgery for Long-bone Fractures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis of this study is to find evidence if there is an influence of spine surgery on
      the serum levels of two proteins secreted from neuronal cells.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The question, if there is an effect on the cerebrospinal system during spine surgery, which
      can be traced by monitoring serum levels of neuromarkers is not yet answered. This study has
      its background from other studies on patients with traumatic brain injury (TBI), in whom
      elevated serum levels of the two neuromarkers S-100B and NSE are associated with injury
      severity, neuronal damage, brain, tissue damage, and outcome. Patients undergoing spine
      surgery with or without pre-existing traumatic neurologic symptoms are planned to be the
      study cohort. Pre- and postoperatively the serum levels of S-100B and NSE are obtained and
      are statistically compared with patients undergoing other types of bone-related surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>S-100B levels</measure>
    <time_frame>4 hours</time_frame>
    <description>average timeframe between blood withdrawal (twice, pre-and post-operatively)</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Spinal Injury</condition>
  <arm_group>
    <arm_group_label>Spine surgery</arm_group_label>
    <description>Patients undergoing spine surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bone surgery</arm_group_label>
    <description>Patients undergoing bone surgery for fracture treatment other than spine fractures</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum levels of the biomarkers S-100B and NSE are measured
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with spine fractures undergoing spine surgery for fracture stabilization
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  spine fracture

        Exclusion Criteria:

          -  additional traumatic brain injury

          -  fractures of the long bones

          -  polytrauma

          -  severely injured patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Harald Wolf, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Vienna, Department for Trauma Surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>A-1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <reference>
    <citation>Cao F, Yang XF, Liu WG, Hu WW, Li G, Zheng XJ, Shen F, Zhao XQ, Lv ST. Elevation of neuron-specific enolase and S-100beta protein level in experimental acute spinal cord injury. J Clin Neurosci. 2008 May;15(5):541-4. doi: 10.1016/j.jocn.2007.05.014. Epub 2008 Mar 14.</citation>
    <PMID>18343116</PMID>
  </reference>
  <reference>
    <citation>Marquardt G, Setzer M, Theisen A, Tews DS, Seifert V. Experimental subacute spinal cord compression: correlation of serial S100B and NSE serum measurements, histopathological changes, and outcome. Neurol Res. 2011 May;33(4):421-6. doi: 10.1179/1743132810Y.0000000005.</citation>
    <PMID>21535942</PMID>
  </reference>
  <reference>
    <citation>Marquardt G, Setzer M, Szelenyi A, Seifert V, Gerlach R. Prognostic relevance of serial S100b and NSE serum measurements in patients with spinal intradural lesions. Neurol Res. 2009 Apr;31(3):265-9. doi: 10.1179/174313209X382287. Epub 2008 Nov 26.</citation>
    <PMID>19040802</PMID>
  </reference>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 23, 2013</study_first_submitted>
  <study_first_submitted_qc>April 24, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 25, 2013</study_first_posted>
  <last_update_submitted>November 20, 2013</last_update_submitted>
  <last_update_submitted_qc>November 20, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 21, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Harald Wolf, MD</investigator_full_name>
    <investigator_title>Dr. Harald Wolf</investigator_title>
  </responsible_party>
  <keyword>S-100B</keyword>
  <keyword>NSE</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

